Cellanome Stock
HealthTechLooking to sell Cellanome stock or options?
Cellanome has developed a distinctive multi-omics platform aimed at analyzing biology with unmatched detail and scale. The company's platform is adept in genome sequencing, microfluidics, and integrated sensors, along with expertise in molecular biology and biochemistry. This empowers scientists to create innovative solutions for intricate biological challenges.
Investors Include:
Triatomic Capital, 8VC, HBM Genomics, Synetro Group, DFJ Growth, General Catalyst, RONA Holdings, DCVC Bio, Premji Invest (US), SV Angel.